Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation

Last updated: June 16, 2025
Sponsor: University of Miami
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Lymphoma

Bone Marrow Transplant

White Cell Disorders

Treatment

Mindfulness Meditation (MM)

Mindfulness-based Music Therapy (MBMT)

Clinical Study ID

NCT05968963
20230726
1R61CA263335-01A1
  • Ages > 18
  • All Genders

Study Summary

The goal of this study is to pilot test an Electronic Health Mindfulness-based Music Therapy Intervention (eMBMT) intervention to improve health-related quality of life (HRQoL) and reduce symptom burden of patients undergoing allogeneic stem cell transplantation (allo-SCT).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • ≥ 18 years of age

  • have a primary diagnosis of myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or non Hodgkin's Lymphoma (NHL)

  • have a treatment plan for an allogeneic hematopoietic stem cell transplant

  • Speak English or Spanish

Exclusion

Exclusion Criteria:

  • history of severe psychiatric illness (e.g., psychosis, active suicidality,inpatient treatment in the past 12 months)

  • severe cognitive impairment (per the short portable mental status questionnaire)

  • hearing impairment

  • active alcohol or substance dependence within the past six months

  • participated in music therapy or mindfulness programs in the past six months

Study Design

Total Participants: 60
Treatment Group(s): 2
Primary Treatment: Mindfulness Meditation (MM)
Phase:
Study Start date:
November 28, 2023
Estimated Completion Date:
October 01, 2025

Connect with a study center

  • University of Miami

    Miami, Florida 33136
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.